A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy
medRxiv April 19, 2023 Jennifer Bennett, Michael D. Blough, Ian Mitchell et al. 3 citations preprint
Abstract This Phase I trial aims to inform the development of safety protocols for psilocybin-assisted therapy. Psychedelics, including psilocybin, are increasingly being recognized as a successful treatment option for many mental health concerns. In order to decrease the risks associated with its clinical use, more data is required regarding its physiological effects in healthy individuals....
DOI: 10.1101/2023.04.12.23288325 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Adverse effect
Blood pressure
Heart rate
+7